(Q53437800)

14 May 2018

title

'Lymphoid' blast crisis of chronic myeloid leukaemia is associated with distinct clinicohaematological features. (English)

1 reference

14 May 2018

1 reference

Cervantes F

1

1 reference

14 May 2018

Villamor N

2

1 reference

14 May 2018

Esteve J

3

1 reference

14 May 2018

Montoto S

4

1 reference

14 May 2018

Rives S

5

1 reference

14 May 2018

Rozman C

6

1 reference

14 May 2018

Montserrat E

7

1 reference

14 May 2018

language of work or name

English

0 references

publication date

1 January 1998

1 reference

14 May 2018

British Journal of Haematology

published in

1 reference

14 May 2018

volume

100

1 reference

14 May 2018

issue

1

1 reference

14 May 2018

page(s)

123-128

1 reference

14 May 2018

A study of prognostic factors in blast crisis of Philadelphia chromosome-positive chronic myelogenous leukaemia

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00542.X

Immunophenotypic, genomic and clinical characteristics of blast crisis of chronic myelogenous leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00542.X

Relation of “lymphoid” phenotype and response to chemotherapy incorporating vincristine-prednisolone in the acute phase of Ph1 positive leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00542.X

Characteristics of accelerated disease in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00542.X

Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00542.X

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00542.X

Terminal Transferase as a Predictor of Initial Responsiveness to Vincristine and Prednisone in Blastic Chronic Myelogenous Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00542.X

352. Note: Conservatism of the Approximation Σ(O - E) 2 /E in the Logrank Test for Survival Data or Tumor Incidence Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00542.X

Characterisation of blast cells during blastic phase of chronic myeloid leukaemia by immunophenotyping--experience in 60 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00542.X

Clonal instability preceding lymphoid blastic transformation of chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00542.X

Clinical significance of the presence of myeloid associated antigens in acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00542.X

Therapy of lymphoid and undifferentiated chronic myelogenous leukemia in blast crisis with continuous vincristine and adriamycin infusions plus high-dose decadron

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00542.X

Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00542.X

10.1046/J.1365-2141.1998.00542.X

21 January 2018

Identifiers

DOI

1 reference

14 May 2018

PubMed ID

9450800

1 reference

14 May 2018